Rituximab induces regression of hepatitis C virus-related membranoproliferative glomerulonephritis in a renal allograft.

Bestard, Oriol

Rituximab induces regression of hepatitis C virus-related membranoproliferative glomerulonephritis in a renal allograft. [electronic resource] - Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association Aug 2006 - 2320-4 p. digital

Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't

0931-0509

10.1093/ndt/gfl266 doi


Antibodies, Monoclonal--therapeutic use
Antibodies, Monoclonal, Murine-Derived
Antigens, CD20--immunology
B-Lymphocyte Subsets--drug effects
Capillaries--chemistry
Complement C4b--analysis
Contraindications
Cryoglobulinemia--drug therapy
Fatty Liver--complications
Female
Follow-Up Studies
Glomerulonephritis, Membranoproliferative--drug therapy
Graft Survival
HLA Antigens--immunology
Hepatitis C, Chronic--complications
Humans
Immunosuppressive Agents--therapeutic use
Interferon-alpha
Kidney Transplantation
Lymphocyte Count
Middle Aged
Peptide Fragments--analysis
Postoperative Complications--drug therapy
Recurrence
Renal Dialysis
Reoperation
Rituximab
Transplantation, Homologous
Viral Load
Viremia--complications